Shorter duration could be explained by the absence of severe quantitative CD4 count defect, the rarer use of immunosuppressive drugs, and the lower proportion of blood positive antigen testing in patients with sarcoidosis than in other patients. The gene discussed is CD4; the disease is sarcoidosis.